Roche gets positive CHMP opinion for Tecentriq plus Avastin to treat liver cancer EP News Bureau Sep 18, 2020 The recommendation from the CHMP is based on results from the Phase III IMbrave150 study, which showed that Tecentriq in…
US FDA declines to approve Merck and Eisai’s liver cancer combo therapy Reuters Jul 9, 2020 The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…
